Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fertilization in Vitro | 63 | 2023 | 1292 | 4.790 |
Why?
|
Endometriosis | 35 | 2024 | 860 | 3.010 |
Why?
|
Reproductive Techniques, Assisted | 15 | 2021 | 496 | 2.700 |
Why?
|
Infertility | 22 | 2022 | 653 | 2.280 |
Why?
|
Embryo Transfer | 24 | 2022 | 522 | 2.140 |
Why?
|
Pregnancy Outcome | 27 | 2022 | 2904 | 1.620 |
Why?
|
Progesterone | 7 | 2022 | 741 | 1.410 |
Why?
|
Infertility, Female | 14 | 2019 | 758 | 1.290 |
Why?
|
Leuprolide | 13 | 2023 | 310 | 1.280 |
Why?
|
Pregnancy Rate | 23 | 2023 | 648 | 1.270 |
Why?
|
Ovulation Induction | 12 | 2023 | 277 | 1.160 |
Why?
|
Live Birth | 10 | 2023 | 512 | 1.080 |
Why?
|
Gonadotropin-Releasing Hormone | 12 | 2018 | 1146 | 0.950 |
Why?
|
Estradiol | 19 | 2022 | 1933 | 0.910 |
Why?
|
Pregnancy | 72 | 2023 | 29712 | 0.870 |
Why?
|
Sperm Injections, Intracytoplasmic | 3 | 2018 | 156 | 0.820 |
Why?
|
Insurance, Health | 5 | 2020 | 2482 | 0.790 |
Why?
|
Insurance Coverage | 5 | 2018 | 1919 | 0.790 |
Why?
|
Abortion, Spontaneous | 5 | 2022 | 530 | 0.710 |
Why?
|
Gonadotropins | 6 | 2017 | 241 | 0.650 |
Why?
|
Norethindrone | 5 | 2018 | 56 | 0.650 |
Why?
|
Preimplantation Diagnosis | 1 | 2021 | 143 | 0.640 |
Why?
|
Uterine Hemorrhage | 3 | 2010 | 240 | 0.620 |
Why?
|
Nafarelin | 6 | 1998 | 27 | 0.600 |
Why?
|
Aneuploidy | 1 | 2021 | 550 | 0.570 |
Why?
|
Hormone Antagonists | 1 | 2017 | 107 | 0.570 |
Why?
|
Estrogens, Conjugated (USP) | 5 | 2018 | 275 | 0.560 |
Why?
|
Anti-Mullerian Hormone | 1 | 2019 | 407 | 0.540 |
Why?
|
Follicle Stimulating Hormone | 7 | 2019 | 725 | 0.520 |
Why?
|
Pregnancy, Multiple | 6 | 2013 | 215 | 0.510 |
Why?
|
Maternal Age | 8 | 2015 | 806 | 0.510 |
Why?
|
Ovary | 6 | 2019 | 958 | 0.500 |
Why?
|
Uterus | 4 | 2013 | 649 | 0.500 |
Why?
|
Oocyte Donation | 2 | 2006 | 52 | 0.490 |
Why?
|
Infertility, Male | 7 | 2014 | 395 | 0.490 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2020 | 3970 | 0.460 |
Why?
|
Economic Recession | 1 | 2014 | 79 | 0.450 |
Why?
|
CA-125 Antigen | 5 | 1998 | 279 | 0.450 |
Why?
|
Pelvic Pain | 3 | 2011 | 294 | 0.450 |
Why?
|
Reproductive Health Services | 1 | 2014 | 87 | 0.450 |
Why?
|
Luteal Phase | 3 | 2010 | 138 | 0.450 |
Why?
|
Fetal Death | 2 | 2015 | 434 | 0.440 |
Why?
|
Ovarian Hyperstimulation Syndrome | 2 | 2009 | 47 | 0.400 |
Why?
|
Female | 140 | 2024 | 389943 | 0.390 |
Why?
|
Insemination, Artificial | 3 | 2022 | 99 | 0.390 |
Why?
|
Endocrinology | 3 | 2008 | 441 | 0.390 |
Why?
|
Menstrual Cycle | 5 | 2010 | 535 | 0.380 |
Why?
|
Blastocyst | 4 | 2022 | 433 | 0.370 |
Why?
|
Peritoneal Diseases | 1 | 2011 | 75 | 0.360 |
Why?
|
Fertility | 5 | 2016 | 771 | 0.360 |
Why?
|
Reproductive Techniques | 2 | 2002 | 41 | 0.360 |
Why?
|
Progestins | 3 | 2006 | 301 | 0.360 |
Why?
|
Gamete Intrafallopian Transfer | 4 | 2005 | 27 | 0.360 |
Why?
|
Cost-Benefit Analysis | 3 | 2021 | 5483 | 0.350 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2011 | 190 | 0.340 |
Why?
|
Adult | 86 | 2021 | 219725 | 0.340 |
Why?
|
Socioeconomic Factors | 6 | 2020 | 7796 | 0.330 |
Why?
|
Self Report | 1 | 2020 | 3709 | 0.320 |
Why?
|
Ovarian Follicle | 5 | 2009 | 244 | 0.320 |
Why?
|
Embryo Implantation | 9 | 2016 | 270 | 0.320 |
Why?
|
Endometrium | 3 | 2006 | 402 | 0.310 |
Why?
|
Embryo, Mammalian | 4 | 2003 | 1674 | 0.300 |
Why?
|
Genetic Testing | 1 | 2021 | 3529 | 0.290 |
Why?
|
Health Services Accessibility | 2 | 2020 | 5382 | 0.290 |
Why?
|
Chromosomes, Human, Y | 1 | 2008 | 161 | 0.280 |
Why?
|
Insemination, Artificial, Homologous | 2 | 1999 | 17 | 0.280 |
Why?
|
Postpartum Period | 1 | 2013 | 1167 | 0.280 |
Why?
|
Humans | 139 | 2024 | 757566 | 0.270 |
Why?
|
Menotropins | 5 | 1999 | 41 | 0.270 |
Why?
|
Injections, Intramuscular | 4 | 2010 | 553 | 0.260 |
Why?
|
Life Style | 2 | 2016 | 3886 | 0.250 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2007 | 251 | 0.250 |
Why?
|
Sex Preselection | 1 | 2005 | 16 | 0.250 |
Why?
|
Hormones | 3 | 1998 | 867 | 0.250 |
Why?
|
Vaginal Creams, Foams, and Jellies | 3 | 2010 | 62 | 0.250 |
Why?
|
Cryopreservation | 3 | 2013 | 717 | 0.240 |
Why?
|
Oocyte Retrieval | 3 | 2010 | 158 | 0.230 |
Why?
|
Oocytes | 5 | 2010 | 1165 | 0.230 |
Why?
|
Chorionic Gonadotropin | 8 | 2009 | 457 | 0.230 |
Why?
|
Embryo Disposition | 1 | 2003 | 14 | 0.230 |
Why?
|
Preservation, Biological | 1 | 2003 | 26 | 0.220 |
Why?
|
Semen Preservation | 1 | 2003 | 35 | 0.220 |
Why?
|
Ovarian Diseases | 4 | 2009 | 137 | 0.220 |
Why?
|
Bone Density | 8 | 2015 | 3530 | 0.220 |
Why?
|
Reproduction | 1 | 2008 | 645 | 0.220 |
Why?
|
Ovarian Cysts | 3 | 1998 | 108 | 0.210 |
Why?
|
Sperm Count | 5 | 2010 | 228 | 0.210 |
Why?
|
Fertility Agents, Female | 5 | 2014 | 101 | 0.210 |
Why?
|
Health Care Costs | 1 | 2016 | 3234 | 0.210 |
Why?
|
Diethylstilbestrol | 2 | 2001 | 87 | 0.200 |
Why?
|
Gynecology | 1 | 2008 | 523 | 0.200 |
Why?
|
Spermatozoa | 2 | 1997 | 630 | 0.200 |
Why?
|
United States | 17 | 2021 | 71902 | 0.190 |
Why?
|
Mullerian Ducts | 2 | 2001 | 201 | 0.190 |
Why?
|
Psychotherapy, Brief | 2 | 2013 | 118 | 0.190 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2024 | 284 | 0.180 |
Why?
|
Obstetrics | 1 | 2008 | 664 | 0.180 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2000 | 71 | 0.180 |
Why?
|
Alcohol Drinking | 4 | 2016 | 4019 | 0.170 |
Why?
|
Treatment Outcome | 23 | 2016 | 64242 | 0.170 |
Why?
|
Estrogens | 6 | 2016 | 1519 | 0.170 |
Why?
|
Pregnancy, High-Risk | 1 | 2000 | 119 | 0.170 |
Why?
|
Uterine Diseases | 2 | 2003 | 108 | 0.170 |
Why?
|
Oligospermia | 2 | 1997 | 59 | 0.170 |
Why?
|
Alcoholism | 2 | 2010 | 1965 | 0.160 |
Why?
|
Longitudinal Studies | 8 | 2018 | 14473 | 0.160 |
Why?
|
Fellowships and Scholarships | 1 | 2008 | 1113 | 0.160 |
Why?
|
Semen | 2 | 2010 | 346 | 0.160 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2001 | 255 | 0.160 |
Why?
|
Age Factors | 9 | 2021 | 18326 | 0.160 |
Why?
|
Fallopian Tube Diseases | 2 | 1999 | 60 | 0.160 |
Why?
|
Exercise | 3 | 2016 | 5788 | 0.150 |
Why?
|
Coitus | 2 | 1998 | 131 | 0.150 |
Why?
|
Infant, Low Birth Weight | 4 | 2015 | 858 | 0.150 |
Why?
|
Leiomyoma | 2 | 2013 | 631 | 0.150 |
Why?
|
Retrospective Studies | 29 | 2023 | 79984 | 0.150 |
Why?
|
Sperm Motility | 4 | 2010 | 265 | 0.150 |
Why?
|
Massachusetts | 7 | 2015 | 8815 | 0.140 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 1997 | 61 | 0.140 |
Why?
|
Double-Blind Method | 10 | 2016 | 12261 | 0.140 |
Why?
|
Pregnancy Trimester, First | 4 | 2006 | 906 | 0.140 |
Why?
|
Pituitary Gland | 1 | 1999 | 637 | 0.130 |
Why?
|
Microinjections | 1 | 1997 | 321 | 0.130 |
Why?
|
Phospholipids | 1 | 2000 | 784 | 0.130 |
Why?
|
Bone Resorption | 2 | 2015 | 719 | 0.130 |
Why?
|
Progesterone Congeners | 2 | 2010 | 44 | 0.130 |
Why?
|
Cervix Mucus | 1 | 1995 | 17 | 0.130 |
Why?
|
Infant, Newborn | 9 | 2015 | 26176 | 0.130 |
Why?
|
Prospective Studies | 22 | 2015 | 54092 | 0.130 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2002 | 1348 | 0.120 |
Why?
|
Chromosome Aberrations | 2 | 2003 | 1764 | 0.120 |
Why?
|
Infant, Small for Gestational Age | 2 | 2015 | 460 | 0.120 |
Why?
|
Fertilization | 2 | 2015 | 197 | 0.120 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1668 | 0.120 |
Why?
|
Karyotyping | 1 | 1997 | 1171 | 0.120 |
Why?
|
Young Adult | 12 | 2020 | 58755 | 0.120 |
Why?
|
Pregnancy, Tubal | 1 | 1994 | 15 | 0.120 |
Why?
|
Genital Diseases, Female | 1 | 1996 | 189 | 0.120 |
Why?
|
DNA | 2 | 2008 | 7200 | 0.120 |
Why?
|
Paternal Age | 1 | 2014 | 87 | 0.120 |
Why?
|
Pregnancy Complications | 5 | 2011 | 2940 | 0.110 |
Why?
|
Sesamum | 1 | 2013 | 20 | 0.110 |
Why?
|
Tissue Donors | 1 | 2003 | 2311 | 0.110 |
Why?
|
Catheter Ablation | 1 | 2007 | 2741 | 0.110 |
Why?
|
Single Embryo Transfer | 1 | 2013 | 29 | 0.110 |
Why?
|
Nut Hypersensitivity | 1 | 2013 | 32 | 0.110 |
Why?
|
Fetal Resorption | 1 | 2013 | 15 | 0.110 |
Why?
|
Ultrasonography | 6 | 2015 | 5951 | 0.110 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2013 | 81 | 0.110 |
Why?
|
Laparoscopy | 3 | 2024 | 2032 | 0.110 |
Why?
|
Term Birth | 1 | 2013 | 140 | 0.110 |
Why?
|
Pain | 6 | 2016 | 5063 | 0.100 |
Why?
|
Smoking | 2 | 2016 | 9036 | 0.100 |
Why?
|
Follicular Phase | 2 | 1992 | 143 | 0.100 |
Why?
|
Phenols | 1 | 2016 | 514 | 0.100 |
Why?
|
Urban Population | 1 | 2020 | 2023 | 0.100 |
Why?
|
Birth Rate | 3 | 2011 | 168 | 0.100 |
Why?
|
Cohort Studies | 13 | 2021 | 41190 | 0.100 |
Why?
|
Gonadotropins, Pituitary | 2 | 2005 | 69 | 0.100 |
Why?
|
Male | 36 | 2016 | 358180 | 0.100 |
Why?
|
Patient Satisfaction | 3 | 2011 | 3440 | 0.100 |
Why?
|
Uterine Neoplasms | 1 | 2001 | 1414 | 0.100 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 1992 | 136 | 0.100 |
Why?
|
Parity | 1 | 2015 | 924 | 0.100 |
Why?
|
Models, Economic | 1 | 2016 | 715 | 0.100 |
Why?
|
Caffeine | 1 | 2016 | 700 | 0.100 |
Why?
|
Adolescent | 13 | 2024 | 87819 | 0.100 |
Why?
|
Preconception Care | 2 | 2006 | 139 | 0.090 |
Why?
|
Clomiphene | 3 | 2014 | 71 | 0.090 |
Why?
|
Autoantibodies | 1 | 2000 | 2116 | 0.090 |
Why?
|
Physicians, Women | 1 | 1997 | 495 | 0.090 |
Why?
|
Oxidative Stress | 1 | 2002 | 3102 | 0.090 |
Why?
|
Drug Therapy, Combination | 6 | 2016 | 6292 | 0.090 |
Why?
|
Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2010 | 29 | 0.090 |
Why?
|
Premature Birth | 4 | 2015 | 1766 | 0.090 |
Why?
|
Cost Savings | 1 | 2016 | 913 | 0.090 |
Why?
|
Gestrinone | 1 | 1990 | 2 | 0.090 |
Why?
|
Norpregnatrienes | 1 | 1990 | 2 | 0.090 |
Why?
|
Menstruation | 3 | 2002 | 307 | 0.090 |
Why?
|
Peanut Hypersensitivity | 1 | 2013 | 211 | 0.090 |
Why?
|
Intestinal Diseases | 1 | 2015 | 504 | 0.090 |
Why?
|
Dendritic Cells | 2 | 2014 | 2720 | 0.090 |
Why?
|
Benzhydryl Compounds | 1 | 2016 | 900 | 0.080 |
Why?
|
Cross-Sectional Studies | 5 | 2020 | 25924 | 0.080 |
Why?
|
Ultrasonography, Prenatal | 2 | 2013 | 1744 | 0.080 |
Why?
|
Amnion | 1 | 2010 | 197 | 0.080 |
Why?
|
Sexuality | 1 | 2011 | 179 | 0.080 |
Why?
|
Pelvis | 1 | 1993 | 732 | 0.080 |
Why?
|
Middle Aged | 18 | 2020 | 219192 | 0.080 |
Why?
|
Quality of Life | 3 | 2016 | 13263 | 0.080 |
Why?
|
Dexamethasone | 1 | 1996 | 1927 | 0.080 |
Why?
|
Follicular Fluid | 1 | 2008 | 92 | 0.080 |
Why?
|
Educational Status | 3 | 2015 | 2511 | 0.080 |
Why?
|
Aging | 3 | 2004 | 8654 | 0.070 |
Why?
|
Time Factors | 8 | 2016 | 39811 | 0.070 |
Why?
|
Infant, Premature | 3 | 2015 | 2094 | 0.070 |
Why?
|
Patient Dropouts | 2 | 2002 | 412 | 0.070 |
Why?
|
Drug Administration Schedule | 5 | 2015 | 4845 | 0.070 |
Why?
|
Internship and Residency | 1 | 2008 | 5854 | 0.070 |
Why?
|
Patients | 1 | 2014 | 902 | 0.070 |
Why?
|
Chimerism | 1 | 2008 | 155 | 0.070 |
Why?
|
Abortion, Therapeutic | 1 | 1986 | 35 | 0.070 |
Why?
|
Dilatation and Curettage | 1 | 1986 | 52 | 0.070 |
Why?
|
Androgens | 2 | 1997 | 1281 | 0.070 |
Why?
|
Doxycycline | 1 | 2008 | 341 | 0.070 |
Why?
|
Counseling | 2 | 2022 | 1540 | 0.070 |
Why?
|
Delayed-Action Preparations | 2 | 2002 | 961 | 0.070 |
Why?
|
Practice Guidelines as Topic | 3 | 2016 | 7366 | 0.070 |
Why?
|
Patient Selection | 4 | 2014 | 4235 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 2141 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2016 | 2212 | 0.060 |
Why?
|
Embryo Culture Techniques | 1 | 2006 | 84 | 0.060 |
Why?
|
Marketing of Health Services | 1 | 2006 | 150 | 0.060 |
Why?
|
Premedication | 1 | 2006 | 247 | 0.060 |
Why?
|
Risk-Taking | 1 | 2011 | 1033 | 0.060 |
Why?
|
Reproductive Medicine | 1 | 2006 | 99 | 0.060 |
Why?
|
Capillary Permeability | 1 | 2008 | 770 | 0.060 |
Why?
|
Medical Records | 1 | 2010 | 1406 | 0.060 |
Why?
|
Motivation | 2 | 2006 | 1996 | 0.060 |
Why?
|
Postal Service | 1 | 2005 | 95 | 0.060 |
Why?
|
Immunotherapy | 1 | 2000 | 4641 | 0.060 |
Why?
|
Boston | 5 | 2018 | 9298 | 0.060 |
Why?
|
Culture Media | 1 | 2006 | 899 | 0.060 |
Why?
|
Posthumous Conception | 1 | 2003 | 11 | 0.060 |
Why?
|
Body Mass Index | 4 | 2013 | 12868 | 0.060 |
Why?
|
Information Storage and Retrieval | 1 | 2009 | 820 | 0.060 |
Why?
|
Risk Reduction Behavior | 1 | 2010 | 1098 | 0.050 |
Why?
|
Cell Culture Techniques | 1 | 2010 | 1664 | 0.050 |
Why?
|
Insemination | 1 | 2022 | 18 | 0.050 |
Why?
|
Population Surveillance | 1 | 2013 | 2599 | 0.050 |
Why?
|
Birth Weight | 1 | 2011 | 2095 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2013 | 5194 | 0.050 |
Why?
|
Tissue Banks | 1 | 2003 | 184 | 0.050 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2011 | 930 | 0.050 |
Why?
|
Mass Screening | 2 | 2010 | 5412 | 0.050 |
Why?
|
Gestational Age | 1 | 2011 | 3565 | 0.050 |
Why?
|
Pathology, Surgical | 1 | 2003 | 151 | 0.050 |
Why?
|
Lipid Peroxides | 1 | 2002 | 74 | 0.050 |
Why?
|
Antitubercular Agents | 1 | 2011 | 1373 | 0.050 |
Why?
|
Risk | 2 | 2011 | 9590 | 0.050 |
Why?
|
Dietary Fats | 1 | 2010 | 1991 | 0.050 |
Why?
|
Placebos | 2 | 1997 | 1661 | 0.050 |
Why?
|
Marital Status | 1 | 2003 | 426 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2013 | 2496 | 0.050 |
Why?
|
Anesthesia, Spinal | 2 | 2008 | 280 | 0.050 |
Why?
|
Ambulatory Care Facilities | 2 | 2010 | 927 | 0.050 |
Why?
|
Regression Analysis | 4 | 2013 | 6337 | 0.050 |
Why?
|
Osteoporosis | 3 | 2011 | 1598 | 0.050 |
Why?
|
Prolactin | 1 | 2003 | 621 | 0.050 |
Why?
|
Placenta Accreta | 1 | 1984 | 237 | 0.050 |
Why?
|
Statistics as Topic | 1 | 2007 | 2357 | 0.050 |
Why?
|
Risk Factors | 10 | 2015 | 73708 | 0.050 |
Why?
|
Motor Activity | 1 | 2010 | 2685 | 0.050 |
Why?
|
Down-Regulation | 2 | 2023 | 2901 | 0.040 |
Why?
|
Patient Education as Topic | 2 | 2011 | 2306 | 0.040 |
Why?
|
Trichomonas Vaginitis | 2 | 1970 | 33 | 0.040 |
Why?
|
Contraceptives, Oral | 1 | 2002 | 554 | 0.040 |
Why?
|
Ploidies | 1 | 2000 | 275 | 0.040 |
Why?
|
Melanoma | 2 | 2007 | 5689 | 0.040 |
Why?
|
Zygote | 1 | 2000 | 115 | 0.040 |
Why?
|
Thyrotropin | 1 | 2003 | 832 | 0.040 |
Why?
|
Anovulation | 1 | 1999 | 54 | 0.040 |
Why?
|
State Government | 1 | 2002 | 381 | 0.040 |
Why?
|
Contraception | 1 | 2002 | 346 | 0.040 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2010 | 1842 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 2005 | 3415 | 0.040 |
Why?
|
Abortion, Induced | 1 | 1984 | 459 | 0.040 |
Why?
|
Hysterosalpingography | 1 | 1998 | 26 | 0.040 |
Why?
|
Death | 1 | 2003 | 674 | 0.040 |
Why?
|
Physicians | 1 | 1997 | 4577 | 0.040 |
Why?
|
Receptors, Progesterone | 1 | 2003 | 1129 | 0.040 |
Why?
|
Blastomeres | 1 | 1998 | 29 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6070 | 0.040 |
Why?
|
Congenital Abnormalities | 1 | 2003 | 704 | 0.040 |
Why?
|
Proteome | 1 | 2008 | 1852 | 0.040 |
Why?
|
Equilin | 1 | 1998 | 2 | 0.040 |
Why?
|
Pilot Projects | 2 | 2006 | 8550 | 0.040 |
Why?
|
Diet | 1 | 2016 | 8001 | 0.040 |
Why?
|
Research | 2 | 2015 | 1974 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12047 | 0.040 |
Why?
|
Observer Variation | 2 | 1995 | 2599 | 0.040 |
Why?
|
Ovulation | 1 | 1998 | 181 | 0.040 |
Why?
|
Incidence | 3 | 2010 | 21217 | 0.040 |
Why?
|
Surgical Procedures, Operative | 1 | 1989 | 1903 | 0.040 |
Why?
|
Ethics, Medical | 1 | 2002 | 783 | 0.040 |
Why?
|
Vasomotor System | 1 | 1998 | 207 | 0.040 |
Why?
|
Databases, Factual | 2 | 2010 | 7927 | 0.040 |
Why?
|
Menstruation Disturbances | 1 | 1998 | 143 | 0.040 |
Why?
|
Overweight | 1 | 2008 | 2407 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2007 | 2638 | 0.040 |
Why?
|
Zygote Intrafallopian Transfer | 1 | 1996 | 2 | 0.030 |
Why?
|
Contraceptives, Oral, Synthetic | 1 | 2016 | 16 | 0.030 |
Why?
|
Immunoradiometric Assay | 1 | 1996 | 20 | 0.030 |
Why?
|
Teriparatide | 1 | 1998 | 227 | 0.030 |
Why?
|
Dysmenorrhea | 1 | 1997 | 97 | 0.030 |
Why?
|
Social Class | 1 | 2005 | 1996 | 0.030 |
Why?
|
UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 1996 | 68 | 0.030 |
Why?
|
HIV Infections | 1 | 2002 | 17270 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2010 | 11469 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2002 | 2223 | 0.030 |
Why?
|
Anesthetics, Intravenous | 1 | 1999 | 396 | 0.030 |
Why?
|
Lidocaine | 1 | 1999 | 537 | 0.030 |
Why?
|
Fentanyl | 1 | 1999 | 434 | 0.030 |
Why?
|
Administration, Intranasal | 1 | 1997 | 471 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2000 | 1373 | 0.030 |
Why?
|
Twins | 2 | 2013 | 339 | 0.030 |
Why?
|
Analgesics, Non-Narcotic | 1 | 1998 | 370 | 0.030 |
Why?
|
Proteomics | 1 | 2008 | 3809 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2003 | 1504 | 0.030 |
Why?
|
Cricetinae | 1 | 1998 | 2427 | 0.030 |
Why?
|
Models, Statistical | 1 | 2009 | 5068 | 0.030 |
Why?
|
Health Behavior | 1 | 2006 | 2613 | 0.030 |
Why?
|
Internet | 1 | 2006 | 3081 | 0.030 |
Why?
|
Acetaminophen | 1 | 1998 | 552 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 14637 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 1997 | 499 | 0.030 |
Why?
|
Smoking Cessation | 1 | 2006 | 2045 | 0.030 |
Why?
|
Bupivacaine | 1 | 1997 | 412 | 0.030 |
Why?
|
Anesthetics, Local | 2 | 1999 | 998 | 0.030 |
Why?
|
Logistic Models | 3 | 2011 | 13221 | 0.030 |
Why?
|
Insulin | 1 | 1988 | 6578 | 0.030 |
Why?
|
Antioxidants | 1 | 2002 | 1665 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 8512 | 0.030 |
Why?
|
Recurrence | 2 | 1997 | 8426 | 0.030 |
Why?
|
Fallopian Tubes | 1 | 1994 | 177 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 1994 | 353 | 0.030 |
Why?
|
Case-Control Studies | 4 | 2010 | 22022 | 0.030 |
Why?
|
Uterine Cervicitis | 2 | 1970 | 31 | 0.030 |
Why?
|
Certification | 1 | 1997 | 418 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 3799 | 0.030 |
Why?
|
Demography | 1 | 1998 | 1645 | 0.030 |
Why?
|
Diphtheria Toxin | 1 | 2014 | 252 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2003 | 4282 | 0.030 |
Why?
|
Comorbidity | 3 | 2015 | 10477 | 0.030 |
Why?
|
Drug Implants | 1 | 1993 | 230 | 0.030 |
Why?
|
Prevalence | 2 | 2015 | 15640 | 0.030 |
Why?
|
Pregnancy, Ectopic | 1 | 1994 | 141 | 0.030 |
Why?
|
Microcomputers | 1 | 1993 | 141 | 0.030 |
Why?
|
Ejaculation | 1 | 1992 | 59 | 0.030 |
Why?
|
Cytoplasm | 1 | 1997 | 1513 | 0.030 |
Why?
|
Blood Proteins | 1 | 1997 | 1173 | 0.030 |
Why?
|
Pregnancy Trimester, Second | 1 | 2015 | 731 | 0.020 |
Why?
|
Tissue Adhesions | 1 | 1993 | 218 | 0.020 |
Why?
|
Mice, Inbred C57BL | 4 | 2014 | 21990 | 0.020 |
Why?
|
Evaluation Studies as Topic | 2 | 1996 | 1628 | 0.020 |
Why?
|
Biopsy | 1 | 2003 | 6757 | 0.020 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2013 | 362 | 0.020 |
Why?
|
Database Management Systems | 1 | 1993 | 257 | 0.020 |
Why?
|
Risk Assessment | 4 | 2015 | 23816 | 0.020 |
Why?
|
Hospitals, Chronic Disease | 1 | 2011 | 8 | 0.020 |
Why?
|
Skin Tests | 1 | 2013 | 637 | 0.020 |
Why?
|
Octamer Transcription Factors | 1 | 2010 | 18 | 0.020 |
Why?
|
Single-Blind Method | 1 | 1995 | 1567 | 0.020 |
Why?
|
Odds Ratio | 2 | 2008 | 9624 | 0.020 |
Why?
|
Pain Measurement | 2 | 1999 | 3523 | 0.020 |
Why?
|
Linear Models | 2 | 2011 | 5856 | 0.020 |
Why?
|
Estrogen Replacement Therapy | 1 | 1997 | 1206 | 0.020 |
Why?
|
Central Nervous System Depressants | 1 | 2011 | 164 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 1996 | 2048 | 0.020 |
Why?
|
Societies, Medical | 2 | 2010 | 3887 | 0.020 |
Why?
|
France | 1 | 2011 | 497 | 0.020 |
Why?
|
Online Systems | 1 | 2010 | 181 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2015 | 1735 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 1998 | 1895 | 0.020 |
Why?
|
Bicycling | 1 | 2010 | 176 | 0.020 |
Why?
|
Asia | 1 | 2011 | 616 | 0.020 |
Why?
|
Acanthosis Nigricans | 1 | 1988 | 47 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2877 | 0.020 |
Why?
|
Leydig Cells | 1 | 1988 | 55 | 0.020 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 1988 | 54 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10749 | 0.020 |
Why?
|
Family Characteristics | 1 | 2014 | 1000 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2011 | 500 | 0.020 |
Why?
|
Algorithms | 1 | 2009 | 13952 | 0.020 |
Why?
|
Africa | 1 | 2011 | 705 | 0.020 |
Why?
|
Granulosa Cells | 1 | 1988 | 115 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2008 | 162 | 0.020 |
Why?
|
Cell Size | 1 | 2010 | 624 | 0.020 |
Why?
|
Somatomedins | 1 | 1988 | 178 | 0.020 |
Why?
|
Organ Size | 1 | 2013 | 2248 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 1998 | 1865 | 0.020 |
Why?
|
Femur | 1 | 1994 | 1301 | 0.020 |
Why?
|
Prognosis | 4 | 2010 | 29488 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 1994 | 1796 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2011 | 809 | 0.020 |
Why?
|
Anesthesia, Intravenous | 1 | 2008 | 130 | 0.020 |
Why?
|
Vitamin D-Binding Protein | 1 | 2008 | 131 | 0.020 |
Why?
|
Quality Control | 1 | 2010 | 825 | 0.020 |
Why?
|
Spine | 1 | 1994 | 1111 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39020 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2014 | 18114 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 2010 | 726 | 0.020 |
Why?
|
Complement C3 | 1 | 2008 | 451 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2015 | 20037 | 0.020 |
Why?
|
Ascites | 1 | 2008 | 338 | 0.020 |
Why?
|
Lipids | 1 | 1998 | 3326 | 0.020 |
Why?
|
Child, Preschool | 2 | 2013 | 42045 | 0.020 |
Why?
|
Animals | 8 | 2014 | 167718 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 12870 | 0.020 |
Why?
|
Antithrombins | 1 | 2008 | 294 | 0.020 |
Why?
|
Comprehension | 1 | 2011 | 618 | 0.020 |
Why?
|
Cell Transplantation | 1 | 2007 | 472 | 0.020 |
Why?
|
Embryonic Development | 1 | 2010 | 716 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3762 | 0.010 |
Why?
|
Fetal Growth Retardation | 1 | 2008 | 579 | 0.010 |
Why?
|
Ethanol | 1 | 2011 | 1324 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 544 | 0.010 |
Why?
|
Edema | 1 | 2008 | 769 | 0.010 |
Why?
|
Hepatitis B Surface Antigens | 1 | 1985 | 301 | 0.010 |
Why?
|
Genes, Viral | 1 | 1985 | 649 | 0.010 |
Why?
|
Polycystic Ovary Syndrome | 1 | 1988 | 376 | 0.010 |
Why?
|
ROC Curve | 2 | 2006 | 3562 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 2008 | 1155 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2010 | 18936 | 0.010 |
Why?
|
Cell Nucleus | 1 | 1992 | 2903 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1262 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 1334 | 0.010 |
Why?
|
Intraoperative Care | 1 | 1986 | 764 | 0.010 |
Why?
|
Drug Combinations | 1 | 2008 | 2020 | 0.010 |
Why?
|
Treatment Failure | 1 | 2008 | 2637 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1999 | 10135 | 0.010 |
Why?
|
Data Collection | 1 | 2011 | 3319 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2008 | 1165 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9514 | 0.010 |
Why?
|
Anesthesia, General | 1 | 2008 | 1165 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 2 | 1970 | 2006 | 0.010 |
Why?
|
Patient Compliance | 1 | 2011 | 2685 | 0.010 |
Why?
|
Diploidy | 1 | 2000 | 132 | 0.010 |
Why?
|
Disease Management | 1 | 2011 | 2495 | 0.010 |
Why?
|
Health Surveys | 1 | 2010 | 4056 | 0.010 |
Why?
|
Attitude to Health | 1 | 2008 | 2024 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2006 | 15207 | 0.010 |
Why?
|
Oogenesis | 1 | 1999 | 124 | 0.010 |
Why?
|
Mice | 4 | 2010 | 81066 | 0.010 |
Why?
|
Pain, Postoperative | 1 | 2008 | 1715 | 0.010 |
Why?
|
Orosomucoid | 1 | 1997 | 47 | 0.010 |
Why?
|
Israel | 2 | 1970 | 721 | 0.010 |
Why?
|
Basal Metabolism | 1 | 1998 | 161 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 1995 | 15781 | 0.010 |
Why?
|
Vaginal Smears | 2 | 1970 | 499 | 0.010 |
Why?
|
Oxygen | 1 | 2008 | 4190 | 0.010 |
Why?
|
Contraceptives, Postcoital, Synthetic | 1 | 1996 | 2 | 0.010 |
Why?
|
Blood Chemical Analysis | 1 | 1998 | 437 | 0.010 |
Why?
|
Gene Frequency | 1 | 2003 | 3612 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 2006 | 2167 | 0.010 |
Why?
|
Urinalysis | 1 | 1998 | 368 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2006 | 2742 | 0.010 |
Why?
|
Luteinizing Hormone | 1 | 1998 | 820 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 12397 | 0.010 |
Why?
|
Cell Movement | 1 | 2007 | 5196 | 0.010 |
Why?
|
Drug Synergism | 1 | 1999 | 1746 | 0.010 |
Why?
|
Bone Remodeling | 1 | 1998 | 578 | 0.010 |
Why?
|
Insulin Resistance | 1 | 1988 | 3941 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2007 | 3526 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1970 | 4019 | 0.010 |
Why?
|
Serum Albumin | 1 | 1997 | 672 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2008 | 15532 | 0.010 |
Why?
|
Potassium Chloride | 1 | 1994 | 230 | 0.010 |
Why?
|
Gonadal Steroid Hormones | 1 | 1997 | 701 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 1994 | 678 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2011 | 5815 | 0.010 |
Why?
|
Mutation | 1 | 1996 | 29929 | 0.010 |
Why?
|
Injections | 1 | 1994 | 829 | 0.010 |
Why?
|
Hypertension | 1 | 2011 | 8502 | 0.010 |
Why?
|
Cervix Uteri | 1 | 1994 | 570 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1998 | 6230 | 0.010 |
Why?
|
Scoliosis | 1 | 1996 | 734 | 0.010 |
Why?
|
Hysterectomy | 1 | 1994 | 852 | 0.000 |
Why?
|
Androstenedione | 1 | 1988 | 131 | 0.000 |
Why?
|
Vagina | 1 | 1994 | 828 | 0.000 |
Why?
|
Marriage | 1 | 1970 | 349 | 0.000 |
Why?
|
Aged | 3 | 2013 | 167890 | 0.000 |
Why?
|
Subcellular Fractions | 1 | 1988 | 532 | 0.000 |
Why?
|
Estrone | 1 | 1988 | 232 | 0.000 |
Why?
|
Rats, Inbred Strains | 1 | 1988 | 2090 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 1985 | 11890 | 0.000 |
Why?
|
Protein Binding | 1 | 1997 | 9312 | 0.000 |
Why?
|
Child | 1 | 2013 | 79782 | 0.000 |
Why?
|
Tissue Distribution | 1 | 1988 | 2263 | 0.000 |
Why?
|
Substrate Specificity | 1 | 1988 | 1788 | 0.000 |
Why?
|
Bone and Bones | 1 | 1994 | 2558 | 0.000 |
Why?
|
Nucleic Acid Hybridization | 1 | 1985 | 1304 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2007 | 13268 | 0.000 |
Why?
|
Mice, Inbred Strains | 1 | 1985 | 1758 | 0.000 |
Why?
|
Liposomes | 1 | 1985 | 777 | 0.000 |
Why?
|
Plasmids | 1 | 1985 | 2275 | 0.000 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1970 | 2823 | 0.000 |
Why?
|
Testosterone | 1 | 1988 | 2465 | 0.000 |
Why?
|
Genetic Vectors | 1 | 1985 | 3379 | 0.000 |
Why?
|
RNA | 1 | 1985 | 2716 | 0.000 |
Why?
|
Rats | 1 | 1988 | 23676 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1994 | 36270 | 0.000 |
Why?
|